{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:32:09Z","timestamp":1785335529714,"version":"3.55.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Natural Killer (NK) cells play a key role in both innate and adaptive immune responses against viruses and tumor cells. Their function relies on the dynamic balance between activating and inhibitory signals, which are mediated by receptors that bind ligands expressed on target cells. While much is known about the function and expression patterns of NK cell activating receptors (NKARs), many of their ligands remain unidentified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>K562 cells were transduced with a shRNA library targeting 15,000 genes and co-cultured with NK cells from healthy donors. Surviving clones were tested in cytotoxicity and degranulation assays. PLAC1 was cloned from JEG3 cells in a lentiviral vector and transfected in K562 cells. PLAC1-related gene expression and survival data were obtained from the TCGA database and analyzed using R. PLAC1 and DSG2 expression in healthy tissues and NK cells was obtained from the HPA database and a GEO dataset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified ten candidate genes whose downregulation in K562 cells decreased NK cell-mediated cytotoxicity to levels comparable to silencing the MICA gene. The most promising candidates were functionally validated through single-target gene silencing and overexpression. Among them, the placenta-specific 1 (<jats:italic>PLAC1<\/jats:italic>) gene stood out, as its inhibition conferred the greatest protection to target cells from NK cell lysis, while overexpression of PLAC1 significantly increased NK cell degranulation. Importantly, PLAC1 was found to interact with NKAR fusion proteins, including NKG2D, DNAM1 NKp44 and NKp30, suggesting its potential involvement in NK cell function. PLAC1 is typically silent in normal tissues, with the exception of placental trophoblasts and testicular germ cells, but is markedly overexpressed in a wide range of tumors. Notably, its prognostic significance appears to be tumor-type specific, associating with either favorable or poor outcomes depending on the cancer context.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our study identifies PLAC1 as a novel potential ligand for NKARs, suggesting it could be a valuable target for pharmacological strategies aimed at enhancing NK cell recognition. This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1537876","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:49:50Z","timestamp":1750225790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors"],"prefix":"10.3389","volume":"16","author":[{"given":"Paolo","family":"Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Cifaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gragera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"D\u2019Alicandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Caforio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Folgiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Melaiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Fruci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049028","article-title":"Human NK cells, their receptors and function","volume":"51","author":"Quatrini","year":"2021","journal-title":"Eur J Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.1810117.x","article-title":"Human natural killer cell receptors and co-receptors","volume":"181","author":"Biassoni","year":"2001","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and its ligands: \u201cOne for all, all for one","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","article-title":"NKG2D ligands: key targets of the immune response","volume":"29","author":"Gonzalez","year":"2008","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153715","article-title":"DNAM-1 activating receptor and its ligands: how do viruses affect the NK cell-mediated immune surveillance during the various phases of infection","volume":"20","author":"Cifaldi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.10.010","article-title":"Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells","volume":"27","author":"Pogge von Strandmann","year":"2007","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni1190","article-title":"Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus","volume":"6","author":"Arnon","year":"2005","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41467-018-03014-4","article-title":"Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1076","article-title":"BloodSpot: a database of healthy and Malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles","volume":"47","author":"Bagger","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.674010","article-title":"Tumor therapeutics work as stress inducers to enhance tumor sensitivity to natural killer (NK) cell cytolysis by up-regulating NKp30 ligand B7-H6","volume":"290","author":"Cao","year":"2015","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"283ra255","DOI":"10.1126\/scitranslmed.aaa2327","article-title":"Clinical impact of the NKp30\/B7-H6 axis in high-risk neuroblastoma patients","volume":"7","author":"Semeraro","year":"2015","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02065-07","article-title":"H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44","volume":"82","author":"Ho","year":"2008","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v122:9","article-title":"Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients","volume":"122","author":"Dong","year":"2008","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1470730","DOI":"10.1080\/2162402X.2018.1470730","article-title":"Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor","volume":"7","author":"Gaggero","year":"2018","journal-title":"Oncoimmunology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-489054","article-title":"Identification of a cellular ligand for the natural cytotoxicity receptor NKp44","volume":"122","author":"Baychelier","year":"2013","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam9628","article-title":"Complement factor P is a ligand for the natural killer cell-activating receptor NKp46","volume":"2","author":"Narni-Mancinelli","year":"2017","journal-title":"Sci Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05912-0","article-title":"The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells","volume":"616","author":"Sen Santara","year":"2023","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19980801)32:4<280::AID-CYTO4>3.0.CO;2-M","article-title":"Kinetics of in vitro natural killer activity against K562 cells as detected by flow cytometry","volume":"32","author":"Zamai","year":"1998","journal-title":"Cytometry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2013.12.002","article-title":"Use of RNAi screens to uncover resistance mechanisms in cancer cells and identify synthetic lethal interactions","volume":"11","author":"Diehl","year":"2014","journal-title":"Drug Discov Today Technol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2000.6302","article-title":"PLAC1, an Xq26 gene with placenta-specific expression","volume":"68","author":"Cocchia","year":"2000","journal-title":"Genomics"},{"key":"B25","article-title":"Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia","volume":"24","author":"Robertson","year":"1996","journal-title":"Exp Hematol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-015-0617-7","article-title":"Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases","volume":"13","author":"Zhu","year":"2015","journal-title":"J Transl Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051049","article-title":"Clinical significance of PDCD4 in melanoma by subcellular expression and in tumor-associated immune cells","volume":"13","author":"Tran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e21549","DOI":"10.1096\/fj.202002566R","article-title":"Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: A review","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1038\/s41467-020-18637-9","article-title":"Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.placenta.2021.06.001","article-title":"PLAC1 affects cell to cell communication by interacting with the desmosome complex","volume":"110","author":"Chen","year":"2021","journal-title":"Placenta"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.22062","article-title":"Plac1 (placenta-specific 1) is essential for normal placental and embryonic development","volume":"79","author":"Jackman","year":"2012","journal-title":"Mol Reprod Dev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1011247","article-title":"A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients","volume":"13","author":"Shembrey","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/path.v226.2","article-title":"Cell-cell connectivity: desmosomes and disease","volume":"226","author":"Brooke","year":"2012","journal-title":"J Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1086\/504393","article-title":"DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"79","author":"Awad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00574-8","article-title":"Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia","volume":"18","author":"Crinier","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1350","article-title":"A placenta-specific gene ectopically activated in many human cancers is essentially involved in Malignant cell processes","volume":"67","author":"Koslowski","year":"2007","journal-title":"Cancer Res"},{"key":"B37","first-page":"53","article-title":"Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer","volume":"39","author":"Yang","year":"2018","journal-title":"Oncol Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.919436","article-title":"Plac1 remodels the tumor immune evasion microenvironment and predicts therapeutic response in head and neck squamous cell carcinoma","volume":"12","author":"Meng","year":"2022","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/mol2.2018.12.issue-8","article-title":"Cancer\/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin\/NICD\/PTEN signaling pathway","volume":"12","author":"Li","year":"2018","journal-title":"Mol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-202978","article-title":"New tumour antigen PLAC1\/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma","volume":"68","author":"Liu","year":"2015","journal-title":"J Clin Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"145072","DOI":"10.1016\/j.gene.2020.145072","article-title":"High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data","volume":"763","author":"Ren","year":"2020","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.5272","article-title":"Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells","volume":"37","author":"Wu","year":"2017","journal-title":"Oncol Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1010428317699131","DOI":"10.1177\/1010428317699131","article-title":"Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma","volume":"39","author":"Yin","year":"2017","journal-title":"Tumour Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1594-z","article-title":"High placenta-specific 1\/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma","volume":"63","author":"Ghods","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B45","first-page":"6","article-title":"Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer","volume":"9","author":"Tchabo","year":"2009","journal-title":"Cancer Immun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.3931","article-title":"p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers","volume":"50","author":"Devor","year":"2017","journal-title":"Int J Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"807849","DOI":"10.1155\/2013\/807849","article-title":"The oncoplacental gene placenta-specific protein 1 is highly expressed in endometrial tumors and cell lines","volume":"2013","author":"Devor","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000957","article-title":"Placenta-specific protein 1 expression in human papillomavirus 16\/18-positive cervical cancers is associated with tumor histology","volume":"27","author":"Devor","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1038\/s41598-018-24022-w","article-title":"Plac1 is a key regulator of the inflammatory response and immune tolerance in mammary tumorigenesis","volume":"8","author":"Yuan","year":"2018","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1856545","DOI":"10.1080\/2162402X.2020.1856545","article-title":"Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma","volume":"10","author":"Hayashi","year":"2020","journal-title":"Oncoimmunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.tice.2020.101480","article-title":"Plac1 promotes nasopharyngeal carcinoma cells proliferation, migration and invasion via Furin\/NICD\/PTEN pathway","volume":"69","author":"Lin","year":"2021","journal-title":"Tissue Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02350-8","article-title":"PLAC1: biology and potential application in cancer immunotherapy","volume":"68","author":"Mahmoudian","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B53","doi-asserted-by":"crossref","first-page":"1327478","DOI":"10.3389\/fonc.2023.1327478","article-title":"Desmoglein-2 as a cancer modulator: friend or foe","volume":"13","author":"Myo Min","year":"2023","journal-title":"Front Oncol"},{"key":"B54","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1537876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:50:01Z","timestamp":1750225801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1537876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2025.1537876"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1537876","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1537876"}}